Scorpion details early data on targeted breast cancer drug as it seeks to challenge Novartis, Roche
Read More
Posts by 3mediaweb
Scorpion raises $150M with sights on the next wave of targeted therapies
Read More
Scorpion snaps up $150M in series C funds to widen clinical plans for cancer pipeline
Read More